Page 30 - Molecule Type News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lung Cancer Drugs Market Seeking Excellent Growth | Pfizer, AstraZeneca PLC, Eli Lilly iCrowd Newswire 12 May 2021, 07:54 GMT+10 A new 93 page research study released with title 'Lung Cancer Drugs Market' provides detailed qualitative and quantitative research to better analyze latest market scenario and staged competition. The study not just covers geographic analysis that includes regions like North America, Europe or Asia but also players analysis with profile such as F. Hoffmann-La Roche Ltd, Bristol–Myers Squibb, Janssen, Amgen, AstraZeneca PLC, Pfizer, Inc., Eli Lilly & Company Ltd, a...

15+ key players and Out of all the emerging therapies, HBI-8000 is expected to capture the maximum patient pool owing to its immunomodulatory function. This oral agent targets class I histone deacetylase causing cell cycle arrest and tumor cell death as the mechanism underlying its single-agent activity against lymphoma. T-cell Leukemia pipeline comprises ASTX 660 (Otsuka Pharmaceutical) is in phase I/II while  Valemetostat and Brentuximab vedotin (Seagen/Takeda) is in Phase II stage of development.  HUYA Bioscience appears to have an upper edge as its therapy, HBI-8000 which is in the ...

Search jobs 03-May-2021 Global Small Molecule API Market Current and Future Trends, Leading Players, Industry Segments and Regional Forecast By 2031 | Says FMI Analyst A recent market study published by Future Market Insights (FMI) on the market offers global industry analysis for 2016-2020 & opportunity assessment for 2021-2031. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the Small Molecule API market, growth prosp...

Biosimilar Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030 The Business Research Company’s Biosimilar Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030 LONDON, GREATER LONDON, UK, April 30, 2021 /EINPresswire.com/ -- Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports The prevalence of chronic diseases is expected to drive the biosimilar monoclonal antibodies market. Biosimilar monoclonal antibo...

Share this article Share this article ResearchAndMarkets.com's offering. microRNA 21 (MIR21) - Drugs in Development, 2021 provides in depth analysis on microRNA 21 (MIR21) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview o...